Clinical Trial Update: Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety and preliminary efficacy of the combination of bortezomib and carboplatin in patients with recurrent or progressive ovarian ep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Paraplatin (Carboplatin)
• Velcade (bortezomib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED